Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion type Assertion NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_head.
- NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion description "[Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_provenance.
- NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion evidence source_evidence_literature NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_provenance.
- NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion SIO_000772 17575153 NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_provenance.
- NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion wasDerivedFrom befree-2016 NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_provenance.
- NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_assertion wasGeneratedBy ECO_0000203 NP615707.RAy3hbriU-v5_LfUePw8ijLN_TqOvAKwJ3aNTr-ASmXhs130_provenance.